Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	1.Improvement of clinical symptoms including fever; headache; diarrhea; breathlessness; cough; anosmia; fatigue and myalgia on 10 point VAS scale 0- no symptom and 10-severe symptom. <br/ >2.Reduction in elevated levels of inflammatory markers such as CRP; LDH Ferritin and D-Dimer. <br/ >3.Changes in blood oxygen level SPO2Timepoint: Screening day3 day5 and day10	1.Improvement of clinical symptoms including fever; headache; diarrhea; breathlessness; cough; anosmia; fatigue and myalgia on 10 point VAS scale 0- no symptom and 10-severe symptom. <br/ >2.Reduction in elevated levels of inflammatory markers such as CRP; LDH Ferritin and D-Dimer. <br/ >3.Changes in blood oxygen level SPO2Timepoint: Screening day3 day5 and day10
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Sept. 8, 2021, 1:30 a.m.	oms	1.Improvement of clinical symptoms including fever; headache; diarrhea; breathlessness; cough; anosmia; fatigue and myalgia on 10 point VAS scale 0- no symptom and 10-severe symptom. <br/ >2.Reduction in elevated levels of inflammatory markers such as CRP; LDH Ferritin and D-Dimer. <br/ >3.Changes in blood oxygen level SPO2Timepoint: Screening day3 day5 and day10	1.Improvement of clinical symptoms including fever; headache; diarrhea; breathlessness; cough; anosmia; fatigue and myalgia on 10 point VAS scale 0- no symptom and 10-severe symptom. <br/ >2.Reduction in elevated levels of inflammatory markers such as CRP; LDH Ferritin and D-Dimer. <br/ >3.Changes in blood oxygen level SPO2Timepoint: Screening day3 day5 and day10